Ironwood Pharmaceuticals Inc (IRWD)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Thomas A. McCourt |
| Employees: | 220 |
| Web site: | ironwoodpharma.com |
|
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
617-621-7722
| |
| Date | Ratio |
|---|---|
| 2019-04-02 | 1194:1000 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation.
Please log in first to see chart